Outset Halts Tablo Sales for Home Use Pending FDA Review of New Features
As Outset has added features improving Tablo since the FDA first cleared it for use, it has now had to submit another 510(k) application to the FDA, thus limiting sales to acute facilities only.
Read the full article » | Posted 07-13-2022
Related Articles
- Baxter Announces Multiple Online Training Videos for Professionals Posted 04-12-2024
- Humana and Strive Health Expand Holistic Partnership to more Humana Members Posted 04-12-2024
- ASN and Home Dialysis University Collaboration to Increase Home Dialysis Posted 04-12-2024
- Telemedicine Can Help Grow Home Dialysis, Reduce Dropout, and Improve Outcomes Posted 03-15-2024